Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(18%)
Results Posted
36%(4 trials)

Phase Distribution

Ph phase_2
4
24%
Ph phase_4
1
6%
Ph phase_1
2
12%
Ph phase_3
4
24%
Ph not_applicable
6
35%

Phase Distribution

2

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
4(23.5%)
Phase 4Post-market surveillance
1(5.9%)
N/ANon-phased studies
6(35.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(4)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Recruiting3
unknown1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (11.8%)
Phase 24 (23.5%)
Phase 34 (23.5%)
Phase 41 (5.9%)
N/A6 (35.3%)

Trials by Status

unknown16%
not_yet_recruiting16%
recruiting318%
completed1165%
withdrawn16%

Recent Activity

3 active trials
Showing 5 of 17
completednot_applicable

Mobile Shared Decision-Making Program for ICU Caregivers

NCT07469878
completedphase_3

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

NCT04770220
recruitingphase_3

Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

NCT06658002
recruitingphase_1

High Potency Cannabis: Acute and Protracted Effects

NCT06859723
recruitingnot_applicable

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion

NCT06211712
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07469878Not Applicable

Mobile Shared Decision-Making Program for ICU Caregivers

Completed
NCT04770220Phase 3

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Completed
NCT06658002Phase 3

Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

Recruiting
NCT06859723Phase 1

High Potency Cannabis: Acute and Protracted Effects

Recruiting
NCT06211712Not Applicable

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion

Recruiting
NCT06627257Phase 1

Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy

Not Yet Recruiting
NCT05138562Phase 2

TUC3PII-01_TU2670 Phase IIa Clinical Study

Completed
NCT04195906Phase 3

Phase 3 Study of SNF472 for Calciphylaxis

Completed
NCT04696458Not Applicable

Effects of a Multispecies Probiotic on Migraine

Unknown
NCT01857310Not Applicable

Folic Acid and Zinc Supplementation Trial (FAZST)

Completed
NCT01991561Phase 2

Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

Completed
NCT03517501Phase 3

The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy

Withdrawn
NCT02744885Not Applicable

Crave Crush Behavioral Study

Completed
NCT03557424Phase 4

BEFORE Study, Efficacy of Refigura

Completed
NCT00218465Phase 2

Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking

Completed
NCT02807649Not Applicable

Effect of Ginko and Cistanche Against Fatigue Symptoms

Completed
NCT01283698Phase 2

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Completed

All 17 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
17